A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess systemic certolizumab pegol (CZP) exposure, the
formation of anti-CZP antibodies and safety of CZP across the course of pregnancy in study
participants with chronic inflammatory diseases.